This study has the following objectives:1. To investigate whether stent (mall)apposition is predictive for strut uncoverage. 2. To investigate the *distribution* of mallapposed struts in both Tryton as conventional stent. 3. To investigate the…
ID
Source
Brief title
Condition
- Coronary artery disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
• Strut apposition as predictor strut uncoverage.
Secondary outcome
• Correlation of strut apposition in different segments.
• Maximum neointimal hyperplasia [NIH] thickness (µm) as predictor for Minimal
lumen area (MLA, in mm2).
Background summary
The treatment of bifurcation lesions is one of the unsolved challenges for
interventional cardiologists. Fifteen to twenty percent of the percutaneous
coronary interventions (PCI) are performed to treat bifurcation lesions.
Patients with bifurcation lesions tend to have more advanced disease and
multiple co-morbidities. Furthermore, bifurcation lesions have been associated
with lower procedural success and a poorer clinical outcome than
non-bifurcation lesions. Therefore new dedicated bifurcation stents are
designed. Some are already on the market, like the Tryton Side Branch stent.
The idea behind its specific design is that it will provide optimal scaffolding
at the carina, with well-apposed struts and also the number of the struts
limited.
Study objective
This study has the following objectives:
1. To investigate whether stent (mall)apposition is predictive for strut
uncoverage.
2. To investigate the *distribution* of mallapposed struts in both Tryton as
conventional stent.
3. To investigate the correlation between OCT-derived maximal neointimal
hyperplasia thickness and 3D QCA-derived minimal lumen area.
Study design
This is a prospective observational study which evaluates stent apposition,
neointimal strut coverage and in-stent restenosis in the new Tryton Side Branch
StentTM after 9 months follow up using optical coherence tomography. All
patients with a bifurcation lesion who are treated with a Tryton Side Branch
Stent in our center are eligible for this study. All these patients are
undergoing nine month follow-up angiography, according to standard clinical
practice for patients with complex lesions. Before angiography, written
informed consent is obtained. In addition to the angiography, OCT is performed
of the stented bifurcation lesion to obtain information about stent apposition,
strut coverage and restenosis. During the angiography we obtain angiographic
views to reconstruct a 3D image of the treated bifurcation lesion.
Study burden and risks
2 guide wires are introduced: 1 in the side branch and 1 in the main vessel,
which gives a small chance of dissection, like always when guide wires are
introduced in the coronary arteries. The follow up coronary angiography is
extended with 5 minutes. So, the extra radiation burden is limited, the
fluroresence time is prolonged with only 1 minute. With the introduction of two
guidewires, there is always a minimal change for dissection or other
complications which are related to coronary catheterization. For the OCT, 16ml
of extra contrast is used for each vessel.
Postbus 22660
1105 AZ
NL
Postbus 22660
1105 AZ
NL
Listed location countries
Age
Inclusion criteria
1. Patients with a bifurcation lesion which are treated with the Tryton Side Branch Stent.
Exclusion criteria
general exclusion criteria:
1. Patients participating in the Tryton IDE trial.
2. Any intercurrent revascularization involving of the Tryton-treated bifurcation lesion
Exclusion criteria related to the optical coherence tomography:
1. Impaired renal function (eGFR <60 ml/min/1,73m2)
2. Any other contra-indication for Optical Coherence Tomography, at discretion of the operator
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL35959.018.11 |